New shRNA vectors for mammalian genetic analysis
$143,237ZIAFY2015CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications, trials & patents
Paper 35727842Paper 31139343Paper 30181243Paper 29795111Paper 29036671Paper 28867293Paper 28603775Paper 28389619Paper 28334828Paper 27891214Paper 23236152Paper 19490893
Abstract
PURPOSE. We aim to develop new mammalian vector systems that express shRNAs and cDNAs efficiently. This will enable us to rapidly introduce defined genetic changes into normal cells to create the desired phenotypes. SIGNIFICANT MATERIALS AND METHODS. Expression vectors for shRNAs and cDNAs that enable the rapid immortalization of primary human cells and the introduction of multiple oncogenic lesions. FY2015 ACCOMPLISHMENT. We have constructed human small airway epithelial cell lines with defined oncogenic perturbations, including KRAS mutations and p53 loss, we showed that these alterations can lead to oncogenic transformation of these cells.
View original record on NIH RePORTER →